news

GoodRx and Focus Script Announce Partnership

GoodRx, America’s #1 source for prescription prices and savings, and Focus Script LLC, a leading independent specialized pharmacy claims management company, today announced an exclusive partnership to introduce the first compound pharmacy cash discount card program. This unique program will give consumers access to pricing information and discounts on specific therapeutic classes of compounded medications, and is designed to deliver a consistent patient and provider experience through a certified network of accredited and credentialed pharmacies.

This marks the first-ever discount network for compounded drugs, a class of medications that account for more than $2 billion in annual sales.

The compound pharmacy cash discount card program will utilize the FocusScript Certified Network. New pharmacies interested in the program will be certified by FocusScript. FocusScript pharmacies are accredited and credentialed through the industry-leading UCAP program, which is administered in an exclusive partnership with the National Association of Boards of Pharmacy (NABP).

Doug Hirsch, co-founder and co-CEO of GoodRx, stated, “Compounded medications are among the most complex prescriptions consumers have the challenge of purchasing. With this new partnership, we are continuing our mission to make prescriptions more affordable for all Americans. We look forward to working with FocusScript to provide patients with the information they need to make better choices when it comes to their health care.”

Cynthia Meiners, President and CEO of FocusScript, stated, “We are excited about the opportunity to work with GoodRx to ensure access to affordable compounding pharmacy for all consumers, while also assuring quality and excellence. We see this partnership as an important extension of our capabilities and in line with our mission to address small but significant pharmacy markets that have a disproportionate impact.”

The program will be made available to consumers and physicians in 2017.

About GoodRx

Many consumers do not realize that drug prices vary greatly from pharmacy to pharmacy, even within the same neighborhood; GoodRx wants to change that. America’s #1 source for prescription prices and savings, the company gathers the most up-to-date prices, co-pays and discounts on medications from nearly every pharmacy in the country and provides this data through its easy-to-use mobile app and website. Founded in 2011, GoodRx saves all Americans - the uninsured, underinsured and insured - over 80 percent on their prescriptions by helping them make more informed purchasing decisions. For further information and to download the free, top-ranked medical app, visit www.GoodRx.com.

About FocusScript

Founded in 2014, FocusScript is dedicated to aligning the right people, shared values and technology needed to organize and oversee the delivery of quality standards, rational pricing and reasonable business practices to small but significant pharmacy markets such as compounding. FocusScript provides the confidence to clients and providers that they can compete in small, complex markets offering optimum quality standards, pricing, and intelligent editing utilizing best practices with diligent oversight. The Company provides access to a network of certified pharmacies that provide specialized and compounded medications. Through an exclusive partnership with the National Association of Boards of Pharmacy (“NABP”), FocusScript’s network of compounding pharmacies are certified through the United Credentialing and Accreditation Program (“UCAP”). Using NABP’s Verified Pharmacy Program (“VPP”) as its foundation, the UCAP program includes a rigorous review of business and quality practices, attestation to a code of conduct, and compounding specific requirements. FocusScript is independent and unbiased, enabling us to work with all stakeholders and suppliers and to compete solely on excellence. For more information, visit www.focusscript.com.

The specific companies identified above do not represent all of Spectrum’s investments, and no assumptions should be made that any investments identified were or will be profitable. View the complete list of our portfolio companies. Spectrum is not responsible for the contents of any third party website linked above, and has not confirmed the accuracy of any information provided therein.